Literature DB >> 16261294

Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.

Christopher J Boos, Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16261294     DOI： 10.1007/s11239-005-3597-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  14 in total

Review 1.  Does atrial fibrillation confer a hypercoagulable state?

Authors:  G Y Lip
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

Review 2.  Does heart failure confer a hypercoagulable state? Virchow's triad revisited.

Authors:  G Y Lip; C R Gibbs
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

3.  Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.

Authors:  Vanessa Roldán; Francisco Marín; Juan G Martínez; Ana García-Herola; Francisco Sogorb; Gregory Y H Lip
Journal:  Am J Cardiol       Date:  2005-04-01       Impact factor: 2.778

4.  Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.

Authors:  Dwayne S G Conway; Lesly A Pearce; Bernard S P Chin; Robert G Hart; Gregory Y H Lip
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

Review 5.  Biomarkers in atrial fibrillation: investigating biologic plausibility, cause, and effect.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

6.  C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?

Authors:  Naoyuki Sata; Naokazu Hamada; Takashi Horinouchi; Shigeru Amitani; Takuya Yamashita; Yukinori Moriyama; Kenkichi Miyahara
Journal:  Jpn Heart J       Date:  2004-05

7.  A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.

Authors:  Sridhar Kamath; Andrew D Blann; Bernard S P Chin; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

8.  Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Authors:  Vanessa Roldán; Francisco Marín; Andrew D Blann; Amaya García; Pascual Marco; Francisco Sogorb; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

Review 9.  The prothrombotic state in hypertension and the effects of antihypertensive treatment.

Authors:  Sunil Nadar; Gregory Y H Lip
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.